Intra-patient dose escalation in Ewing’s sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review

BACKGROUND: Data suggests that males experience less toxicity and poorer survival than females treated for Ewing’s sarcoma. We instituted an intra-patient dose escalation (DE) policy with Vincristine/Doxorubicin/Cyclophosphamide (VDC) alternating with Ifosfamide/Etoposide (IE) based on hematological...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewin, Jeremy, Wieringa, Samantha, Collins, Marnie, Desai, Jayesh, Orme, Lisa, Lingaratnam, Senthil, Thomas, David M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866566/
https://www.ncbi.nlm.nih.gov/pubmed/24321600
http://dx.doi.org/10.1186/2045-3329-3-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866566/
https://www.ncbi.nlm.nih.gov/pubmed/24321600
http://dx.doi.org/10.1186/2045-3329-3-15

Ejemplares similares